Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 3136 | 45.94 |
09:34 ET | 1000 | 46.1 |
09:36 ET | 1566 | 46.09 |
09:38 ET | 1850 | 46.2 |
09:39 ET | 200 | 46.15 |
09:41 ET | 350 | 46.1798 |
09:43 ET | 500 | 46.1 |
09:45 ET | 6005 | 46.1 |
09:48 ET | 2706 | 45.88 |
09:50 ET | 600 | 45.99 |
09:52 ET | 600 | 46.15 |
09:54 ET | 396 | 46.22 |
09:56 ET | 300 | 46.2 |
09:57 ET | 431 | 46.13 |
09:59 ET | 1830 | 46.495 |
10:01 ET | 1801 | 46.17 |
10:03 ET | 100 | 46.14 |
10:06 ET | 1257 | 46.07 |
10:08 ET | 400 | 46.07 |
10:10 ET | 4706 | 46.01 |
10:12 ET | 1400 | 45.875 |
10:14 ET | 500 | 45.695 |
10:15 ET | 4665 | 45.97 |
10:17 ET | 2500 | 45.91 |
10:19 ET | 2995 | 46 |
10:21 ET | 658 | 46.05 |
10:24 ET | 2100 | 46.005 |
10:26 ET | 300 | 46.02 |
10:28 ET | 1000 | 45.86 |
10:30 ET | 2464 | 45.825 |
10:32 ET | 4715 | 45.93 |
10:33 ET | 13716 | 46.03 |
10:35 ET | 471 | 46.01 |
10:37 ET | 300 | 46.04 |
10:39 ET | 2353 | 46.08 |
10:42 ET | 564 | 46.1 |
10:44 ET | 1250 | 46.085 |
10:46 ET | 1800 | 46.015 |
10:48 ET | 1607 | 45.97 |
10:50 ET | 2886 | 46.06 |
10:51 ET | 1200 | 45.98 |
10:53 ET | 3291 | 45.925 |
10:55 ET | 3703 | 45.85 |
10:57 ET | 1904 | 45.925 |
11:00 ET | 8135 | 46.12 |
11:02 ET | 10679 | 46.18 |
11:04 ET | 1041 | 46.185 |
11:06 ET | 1800 | 46.18 |
11:08 ET | 2756 | 46.19 |
11:09 ET | 3800 | 46.33 |
11:11 ET | 1456 | 46.39 |
11:13 ET | 4164 | 46.455 |
11:15 ET | 1513 | 46.465 |
11:18 ET | 2602 | 46.46 |
11:20 ET | 3668 | 46.43 |
11:22 ET | 7532 | 46.37 |
11:24 ET | 2054 | 46.435 |
11:26 ET | 3881 | 46.505 |
11:27 ET | 1780 | 46.515 |
11:29 ET | 300 | 46.54 |
11:31 ET | 400 | 46.55 |
11:33 ET | 3220 | 46.66 |
11:36 ET | 1483 | 46.73 |
11:38 ET | 1600 | 46.73 |
11:40 ET | 9345 | 46.795 |
11:42 ET | 1789 | 46.89 |
11:44 ET | 835 | 46.89 |
11:45 ET | 1100 | 46.92 |
11:47 ET | 500 | 46.94 |
11:49 ET | 13399 | 46.76 |
11:51 ET | 7595 | 46.66 |
11:54 ET | 8316 | 46.595 |
11:56 ET | 800 | 46.45 |
11:58 ET | 4341 | 46.61 |
12:00 ET | 1100 | 46.5 |
12:02 ET | 700 | 46.5 |
12:03 ET | 5995 | 46.44 |
12:05 ET | 901 | 46.37 |
12:07 ET | 600 | 46.27 |
12:09 ET | 500 | 46.29 |
12:12 ET | 2066 | 46.27 |
12:14 ET | 500 | 46.24 |
12:16 ET | 5500 | 46.22 |
12:18 ET | 7076 | 46.265 |
12:20 ET | 2800 | 46.42 |
12:21 ET | 2216 | 46.44 |
12:23 ET | 816 | 46.4 |
12:25 ET | 200 | 46.42 |
12:27 ET | 400 | 46.395 |
12:30 ET | 7000 | 46.355 |
12:32 ET | 2147 | 46.395 |
12:34 ET | 985 | 46.37 |
12:36 ET | 660 | 46.34 |
12:38 ET | 1901 | 46.2825 |
12:39 ET | 1907 | 46.24 |
12:41 ET | 300 | 46.19 |
12:43 ET | 928 | 46.14 |
12:45 ET | 2900 | 46.24 |
12:48 ET | 242 | 46.171 |
12:50 ET | 200 | 46.155 |
12:52 ET | 686 | 46.125 |
12:54 ET | 1595 | 46.14 |
12:56 ET | 1200 | 46.105 |
12:57 ET | 1991 | 46.16 |
12:59 ET | 2200 | 46.18 |
01:01 ET | 800 | 46.04 |
01:03 ET | 300 | 46.07 |
01:06 ET | 100 | 46.04 |
01:08 ET | 2489 | 46.12 |
01:10 ET | 426 | 46.11 |
01:12 ET | 400 | 46.095 |
01:14 ET | 555 | 46.125 |
01:15 ET | 500 | 46.12 |
01:17 ET | 500 | 46.09 |
01:19 ET | 100 | 46.09 |
01:21 ET | 500 | 46.085 |
01:24 ET | 2684 | 46.07 |
01:26 ET | 5927 | 46.09 |
01:28 ET | 877 | 46.07 |
01:30 ET | 300 | 46.02 |
01:32 ET | 600 | 45.92 |
01:33 ET | 200 | 45.935 |
01:35 ET | 2523 | 45.91 |
01:37 ET | 470 | 45.94 |
01:39 ET | 200 | 45.94 |
01:42 ET | 2457 | 45.885 |
01:44 ET | 3073 | 45.955 |
01:46 ET | 1903 | 45.9 |
01:48 ET | 1462 | 45.9 |
01:50 ET | 1323 | 45.97 |
01:51 ET | 3345 | 46.02 |
01:53 ET | 5217 | 46.015 |
01:55 ET | 1477 | 46.01 |
01:57 ET | 1886 | 46.015 |
02:00 ET | 3794 | 46.01 |
02:02 ET | 2455 | 45.92 |
02:04 ET | 700 | 45.95 |
02:06 ET | 1200 | 45.89 |
02:08 ET | 800 | 45.92 |
02:09 ET | 1000 | 45.95 |
02:11 ET | 9775 | 45.92 |
02:13 ET | 1441 | 45.935 |
02:15 ET | 4412 | 45.82 |
02:18 ET | 524 | 45.84 |
02:20 ET | 1304 | 45.8 |
02:22 ET | 2100 | 45.94 |
02:24 ET | 2206 | 45.95 |
02:26 ET | 1000 | 45.98 |
02:27 ET | 1301 | 46.015 |
02:29 ET | 4529 | 45.915 |
02:31 ET | 3655 | 45.96 |
02:33 ET | 4387 | 45.9 |
02:36 ET | 6801 | 45.79 |
02:38 ET | 1603 | 45.83 |
02:40 ET | 3428 | 45.79 |
02:42 ET | 1800 | 45.81 |
02:44 ET | 700 | 45.825 |
02:45 ET | 3177 | 45.87 |
02:47 ET | 2214 | 45.88 |
02:49 ET | 2500 | 45.91 |
02:51 ET | 2571 | 45.91 |
02:54 ET | 1502 | 45.91 |
02:56 ET | 300 | 45.91 |
02:58 ET | 3152 | 45.81 |
03:00 ET | 11663 | 45.76 |
03:02 ET | 18892 | 45.64 |
03:03 ET | 7667 | 45.705 |
03:05 ET | 4318 | 45.76 |
03:07 ET | 1544 | 45.73 |
03:09 ET | 700 | 45.75 |
03:12 ET | 1100 | 45.715 |
03:14 ET | 1077 | 45.76 |
03:16 ET | 2119 | 45.74 |
03:18 ET | 1057 | 45.765 |
03:20 ET | 1300 | 45.77 |
03:21 ET | 4986 | 45.62 |
03:23 ET | 2220 | 45.66 |
03:25 ET | 1200 | 45.66 |
03:27 ET | 2900 | 45.6 |
03:30 ET | 3000 | 45.69 |
03:32 ET | 4729 | 45.845 |
03:34 ET | 1545 | 45.85 |
03:36 ET | 1214 | 45.84 |
03:38 ET | 1461 | 45.83 |
03:39 ET | 9513 | 45.84 |
03:41 ET | 5175 | 45.775 |
03:43 ET | 5367 | 45.73 |
03:45 ET | 3900 | 45.64 |
03:48 ET | 6698 | 45.665 |
03:50 ET | 8037 | 45.63 |
03:52 ET | 10293 | 45.64 |
03:54 ET | 9699 | 45.63 |
03:56 ET | 15301 | 45.58 |
03:57 ET | 21087 | 45.49 |
03:59 ET | 62874 | 45.57 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 8.0B | -17.5x | --- |
Ascendis Pharma A/S | 8.1B | -14.2x | --- |
Blueprint Medicines Corp | 6.6B | -21.4x | --- |
Insmed Inc | 9.4B | -10.9x | --- |
Vaxcyte Inc | 8.0B | -16.8x | --- |
Intra-Cellular Therapies Inc | 7.2B | -59.4x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.0B |
---|---|
Revenue (TTM) | $342.8M |
Shares Outstanding | 182.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.09 |
EPS | $-2.60 |
Book Value | $6.88 |
P/E Ratio | -17.5x |
Price/Sales (TTM) | 23.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -157.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.